Multi Center Case Control Study on Multiple Risk Factors of Aplastic Anemia
NCT03208647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1802
Last updated 2017-07-05
Summary
To ascertain the risk factors of AA in ZheJiang Province of China at the moment, especially the comprehensive multiple factors risks. The author conducted a case-control research included 338 AA cases and 1464 controls. Subjects were surveyed using same standard questionnaire including personal data, past histories of diseases, family history and histories of occupational and daily exposure to harmful substances. Single and multiple Logistic regression analyses were made using SPSS17.0 on the dates to study potential factors in the development of AA.
Conditions
- Aplastic Anemia
Interventions
- OTHER
-
AA or not
to study their risk factors
Sponsors & Collaborators
-
Shengyun Lin
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-01-01
- Primary Completion
- 2014-01-01
- Completion
- 2014-01-01
More Related Trials
-
Association Between Anaemia and Handgrip Strength in Female Planned for Major Surgery and the Effect of Intravenous Iron on Handgrip Strength
NCT04642521 ·Status: UNKNOWN
-
IRON DEFICIENCY ANEMIA IN RELATION TO PINCH STRENGTH AND HAND DEXTERITY IN PRESCHOOL CHILDREN
NCT05959122 ·Status: COMPLETED
-
The Effective and Safety of Thalidomide in NTDT
NCT02995707 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
NCT00982007 ·Status: COMPLETED ·Phase: PHASE3
-
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
NCT02541708 ·Status: UNKNOWN ·Phase: PHASE3
-
Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data
NCT00005307 ·Status: COMPLETED
-
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia
NCT00704028 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
NCT00102245 ·Status: TERMINATED
-
Allograft for Sickle Cell Disease and Thalassemia
NCT02038478 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
NCT02384122 ·Status: COMPLETED ·Phase: PHASE3
-
Anemia in the Elderly
NCT00640172 ·Status: COMPLETED
-
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia
NCT00703937 ·Status: COMPLETED ·Phase: PHASE3
-
Steroid Injection for Sickle Cell Arthropathy Pain Therapy
NCT05983055 ·Status: COMPLETED
-
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load
NCT02831712 ·Status: UNKNOWN ·Phase: NA
-
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
NCT01309659 ·Status: TERMINATED ·Phase: PHASE2
-
Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease
NCT05861453 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA
NCT03764618 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia
NCT01546415 ·Status: COMPLETED ·Phase: PHASE4
-
Frequency and Impact of Iron Deficiency in Pain Clinic Patients
NCT06665516 ·Status: COMPLETED
-
Assessment of Pain in People With Thalassemia
NCT00872339 ·Status: COMPLETED
-
Etiology of Anemia
NCT00302939 ·Status: TERMINATED
-
A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome
NCT00095264 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients
NCT06708728 ·Status: NOT_YET_RECRUITING
-
Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease
NCT00459225 ·Status: WITHDRAWN ·Phase: NA
-
Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy
NCT01588665 ·Status: COMPLETED